Black patients with inherited retinal diseases who undergo genetic testing are less likely than White patients to receive a ...

The genetic testing rate is lower for Black than non-Hispanic White patients with inherited retinal diseases (IRDs), ...

Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Splicing accuracy enhanced This process is crucial for the life of the cell. "The spliceosome is composed of multiple components that secure production of functional proteins controlling cellular life ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

Finalized the design of the Phase 2 KLARITY trial of KIO-104, a small molecule targeting the treatment of multiple retinal inflammatory diseases, with submission for trial approval on track for Q4 ...

AlloVir has entered into a definitive agreement for the acquisition of the complete outstanding shares of Kalaris ...

The Korea Research Institute of Standards and Science (KRISS) announced that they have developed an advanced disease ...